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Endocannabinoids (eCBs) have emerged as key
activity-dependent signals that, by activating
presynaptic cannabinoid receptors (i.e., CB1)
coupled to Gi/o protein, can mediate short-
term and long-term synaptic depression (LTD).
While the presynaptic mechanisms underlying
eCB-dependent short-term depression have
been identified, the molecular events linking
CB1 receptors to LTD are unknown. Here we
show in the hippocampus that long-term, but
not short-term, eCB-dependent depression of
inhibitory transmission requires presynaptic
cAMP/PKA signaling. We further identify the
active zone protein RIM1a as a key mediator
of both CB1 receptor effects on the release ma-
chinery and eCB-dependent LTD in the hippo-
campus. Moreover, we show that eCB-depen-
dent LTD in the amygdala and hippocampus
shares major mechanistic features. These find-
ings reveal the signaling pathway by which CB1
receptors mediate long-term effects of eCBs in
two crucial brain structures. Furthermore, our
results highlight a conserved mechanism of
presynaptic plasticity in the brain.
INTRODUCTION
The endogenous ligands of cannabinoid receptors (endo-
cannabinoids, or eCBs) are important regulators of synap-
tic function (Alger, 2002; Freund et al., 2003) mediating
short- and long-term plasticity at both excitatory and inhib-
itory synapses in a number of brain structures (for a recent
review, see Chevaleyre et al., 2006). These lipid signaling
molecules are generally synthesized ‘‘on demand’’ from
membrane precursors in the postsynaptic cell, and diffuse
retrogradely to the presynaptic terminal (Piomelli, 2003).
Once bound to the presynaptic cannabinoid receptor
CB1, eCBs suppress transmitter release either transiently
(<1 min) (Diana and Marty, 2004; Kreitzer and Regehr,2002; Wilson and Nicoll, 2002) or in a consolidated long-
term form (>1 hr) (Chevaleyre et al., 2006; Gerdeman and
Lovinger, 2003) that persists long after CB1 receptor acti-
vation has ceased (Chevaleyre and Castillo, 2003; Robbe
et al., 2002; Ronesi et al., 2004; Sjostrom et al., 2003).
How activation of the same presynaptic receptor leads
to transient versus long-lasting depression remains
unknown.
At present, eCB-mediated long-term depression (eCB-
LTD) probably constitutes the best documented and
most widely distributed form of activity-dependent, long-
term presynaptic plasticity in the brain (Chevaleyre et al.,
2006; Gerdeman and Lovinger, 2003). Examples of
presynaptic eCB-LTD have been reported at excitatory
synapses in dorsal striatum (Gerdeman et al., 2002; Kreit-
zer and Malenka, 2005), nucleus accumbens (Robbe et al.,
2002), neocortex (Bender et al., 2006; Sjostrom et al.,
2003), and cerebellum (Soler-Llavina and Sabatini,
2006), and at inhibitory synapses in hippocampus (Cheva-
leyre and Castillo, 2003; Chevaleyre and Castillo, 2004)
and amygdala (then termed I-LTD) (Azad et al., 2004; Mar-
sicano et al., 2002). This prevalence suggests that eCB-
LTD may be a fundamental mechanism for making long-
term modifications to neural circuits and behavior. On
the other hand, transient, eCB-mediated depression of
synaptic transmission is exemplified by the phenomenon
known as Depolarization-induced Suppression of Inhibi-
tion (or Excitation) (DSI or DSE, respectively), a phenome-
non well characterized in the hippocampus and cerebel-
lum, but also observed in other brain areas (reviewed in
Alger, 2002; Diana and Marty, 2004; Kreitzer and Regehr,
2002; and Wilson and Nicoll, 2002). It is worth noting that
by regulating GABA release, eCBs can also modify the in-
ducibility of non-eCB-mediated forms of synaptic plastic-
ity, such as long-term potentiation (LTP) (Azad et al., 2004;
Carlson et al., 2002; Chevaleyre and Castillo, 2004). There-
fore, whether eCBs engage transient or long-lasting de-
pression may profoundly impact neural circuit processing.
A mechanism for the transient suppression of release in
DSI/DSE has been suggested by studies in hippocampus
(Lenz et al., 1998; Varma et al., 2002; Wilson et al., 2001)
and cerebellum (Kreitzer and Regehr, 2001). Namely,
CB1 receptor activation transiently inhibits presynaptic
voltage-gated Ca2+ channels (VGCC) for a period ofNeuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc. 801
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subunits (Wilson et al., 2001). One of the most striking re-
quirements distinguishing I-LTD induction from that of DSI
is the extended duration of CB1 receptor activity (Cheva-
leyre and Castillo, 2003). This increased time requirement
for I-LTD induction could reflect the recruitment of a
distinct signaling pathway by CB1 receptors. A likely can-
didate pathway for I-LTD is the ai/o effector limb of the CB1
receptor G protein signaling cascade, i.e., the cAMP/Pro-
tein Kinase A (PKA) pathway (Childers and Deadwyler,
1996; Howlett et al., 1986). Indeed, modulation of the
cAMP/PKA pathway has been implicated in other presyn-
aptic forms of plasticity in both hippocampus (Huang
et al., 1994; Tzounopoulos et al., 1998; Villacres et al.,
1998; Weisskopf et al., 1994) and cerebellum (Linden
and Ahn, 1999; Salin et al., 1996; Storm et al., 1998). A
common theme of these long-term forms of plasticity is
that their expression mechanism relies on changes in the
transmitter release machinery (Castillo et al., 1997, 2002;
Lonart et al., 2003; Tzounopoulos et al., 1998). In particu-
lar, the active zone protein RIM1a (Wang et al., 1997) has
been shown to be necessary for PKA-dependent LTP at
several excitatory synapses, including the mossy fiber to
CA3 pyramidal cell synapse (Castillo et al., 2002), the
parallel fiber to Purkinje cell synapse (Castillo et al.,
2002; Lonart et al., 2003), and the Schaffer collateral to
CA1 pyramidal synapse (Huang et al., 2005). These previ-
ous studies prompted us to ask whether eCB-LTD also
involves downregulation of the cAMP/PKA pathway, a
RIM1a-dependent modification of the release machinery,
or both.
In this study, we compared the dependence of DSI and
I-LTD on both cAMP/PKA signaling and the active zone
protein RIM1a. We found that hippocampal I-LTD, but
not DSI, requires cAMP/PKA signaling and RIM1a. In ad-
dition, we report that CB1 receptors, via PKA, regulate
GABA release downstream of VGCC-mediated Ca2+ in-
flux, and that both CB1 receptors and PKA can target
the release machinery in a RIM1a-dependent manner.
Furthermore, we tested the generality of these mecha-
nisms in the basolateral amygdala (BLA) where eCBs me-
diate I-LTD (Azad et al., 2004; Marsicano et al., 2002). At
inhibitory synapses in the BLA, we also found that CB1 re-
ceptors target the release machinery via PKA and that
RIM1a is necessary for I-LTD. Taken together, these find-
ings raise the intriguing prospect of a core mechanism of
presynaptic plasticity spanning multiple brain areas and
synapse types (i.e., excitatory and inhibitory), and also
provide a potential substrate for the hippocampus- and
amygdala-dependent memory deficits reported in RIM1a
KO mice (Powell et al., 2004).
RESULTS
During hippocampal DSI, CB1 receptor-mediated block of
the N-type VGCC is believed to depress GABA release
(Varma et al., 2002; Wilson et al., 2001). On the other
hand, the CB1 receptors’ effectors during I-LTD are com-802 Neuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc.pletely unknown. Because CB1 receptors are Gi/o coupled
(Howlett et al., 2002) and have a well-documented inhibi-
tory effect on adenylyl cyclase and PKA activity (Childers
and Deadwyler, 1996; Howlett et al., 1986), we tested
whether the cAMP/PKA pathway might be involved in
eCB-mediated long-term plasticity in slices of mouse hip-
pocampus. First, cAMP levels were raised by continuous
activation of adenylyl cyclase with forskolin (FSK), a
manipulation that also increased the amplitude of evoked
inhibitory postsynaptic currents (IPSCs) by 25.0% ± 5.4%
(n = 6). Theta-burst stimulation (TBS) of presynaptic in-
puts, which triggered I-LTD under control conditions (Fig-
ure 1A; 23.8% ± 2.0%, n = 4), failed in the presence of
FSK (Figure 1A; 3.8% ± 3.1%, n = 5, p = 0.0014). Changes
in cAMP level can affect synaptic transmission through
both PKA-dependent and -independent actions (Seino
Figure 1. Endocannabinoid-Mediated Long-Term, but Not
Short-Term, Plasticity Requires cAMP/PKA Signaling
(A) A persistent increase in cAMP level by incubation (>30 min) and
continuous bath application of the adenylyl cyclase activator forskolin
(FSK) (10 mM) blocked I-LTD.
(B) Incubation and continuous application of either of two different PKA
inhibitors (10 mM H89, n = 4; 1 mm PKI 14-22 amide, n = 7) also impaired
I-LTD induction. Direct application of a membrane-impermeant PKA
blocker (1 mM PKI 6-22 amide, n = 7) to the postsynaptic pyramidal
cell, via recording pipette, did not affect I-LTD.
(C) None of these manipulations interfered with DSI. Averaged sample
traces taken at times indicated by numbers are shown on the right.
Error bars, ± SEM.
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of PKA with two different blockers, the cell-permeable
myristoylated form of PKA inhibitor 14-22 amide (PKI)
and H89. I-LTD was markedly reduced after incubating
slices for >30 min with either of these compounds
(Figure 1B; PKA blocker 5.2% ± 1.8%, n = 11, 7 cells in
PKI and 4 cells in H89 [data were combined since no dif-
ferential effect was observed by these blockers] versus
20.8% ± 2.0%, n = 6 in interleaved control slice, p <
0.0001). This result likely represents an occlusion of
I-LTD, given that CB1 receptors can downregulate PKA
activity and that PKA inhibition acutely depresses synaptic
transmission (see below, Figure 5B).
In order to rule out a postsynaptic role for PKA in I-LTD
induction, I-LTD was also tested with the nonmyristoy-
lated, membrane impermeant form of PKI, delivered to
the postsynaptic cell via the recording pipette. Blocking
postsynaptic PKA did not affect I-LTD (Figure 1B), indicat-
ing that the PKA requirement is presynaptic. In marked
contrast to these effects on long-term plasticity, neither
FSK nor PKA blockers altered DSI in the same CA1 pyra-
midal cells (Figure 1C), in accordance with previous
findings (Morishita et al., 1998; Wilson et al., 2001). We ob-
tained results similar to these with FSK and PKA inhibitors
for I-LTD and DSI in brain slices from rats (data not shown).
We considered the possibility that interfering with cAMP/
PKA signaling blocked I-LTD by reducing glutamate re-
lease, which is the initial trigger for I-LTD (Chevaleyre
and Castillo, 2003). However, neither PKA blockers nor
FSK depressed excitatory synaptic transmission (i.e.,
CA1 field potentials) after 50 min bath application (PKI:
1.3% ± 2.1%, n = 6; H89: 0.5% ± 3.2%, n = 5; FSK:
24.4% ± 5.3%, n = 4; data not shown). Taken together,
these results show that the presynaptic cAMP/PKA path-
way is required downstream of CB1 receptor activation for
long-term, but not short-term, eCB-mediated plasticity.
If CB1 receptors can regulate GABA release, as shown
above, by two divergent signaling cascades, it stands to
reason that this receptor may also independently target
distinct steps of neurotransmitter release. In the hippo-
campus, previous studies have suggested that CB1 re-
ceptors suppress GABA release mainly by targeting
VGCCs rather than the vesicle release machinery (Hoff-
man and Lupica, 2000; Varma et al., 2002; Wilson et al.,
2001; Wilson and Nicoll, 2001). In the cerebellum, how-
ever, CB1 receptors can target the release machinery in
a manner that presumably depends on basal Ca2+ levels
in the presynaptic terminal (Yamasaki et al., 2006). For
this reason, we chose to examine miniature IPSCs
(mIPSCs) in CA1 in the presence of 5 mM extracellular
Ca2+, blocking action potentials and VGCCs with 500
nM TTX and 100 mM CdCl2, respectively. Application of
5 mM WIN 55,212-2 (WIN), a CB1 receptor agonist, signif-
icantly decreased mIPSC frequency in the hippocampus
(Figure 2A; 17.6% ± 1.2%, n = 5, p = 0.0002). This effect
was blocked by a CB1 receptor antagonist, AM 251 or
SR 141716 (Figure 2A). In addition, WIN had no effect on
mIPSC amplitude (Figure 2B), indicating a presynaptic ac-tion of CB1 receptors on GABA release. As the cAMP/PKA
pathway is required for I-LTD induction, we tested
whether it is also involved in CB1 receptor-mediated de-
pression of mIPSC frequency. In presence of FSK, mIPSC
frequency was increased (by 58.1%, n = 6, p = 0.003) and
WIN was unable to depress mIPSC frequency (Figure 2C).
Furthermore, blocking PKA with H89 reduced mIPSC fre-
quency to the same extent as WIN alone, and the effects of
WIN and H89 did not summate, again suggesting occlu-
sion (Figure 2C). These results show that in addition to pre-
synaptic VGCCs, CB1 receptors can also target the re-
lease machinery via the cAMP/PKA pathway.
What lies downstream of PKA in I-LTD? To address this
question, we tested whether RIM1a, a presynaptic active
zone protein (Schoch et al., 2002; Wang et al., 1997) that is
phosphorylated by PKA (Lonart et al., 2003) and is re-
quired for presynaptic forms of LTP at excitatory synapses
(Castillo et al., 2002; Lonart et al., 2003), could also be in-
volved in I-LTD. Notably, I-LTD induced by a TBS was
abolished in RIM1a KO mice (Figure 3A; 3.9% ± 1.3%,
n = 18 cells, 10 KO mice, versus 19.1% ± 1.8%, n = 14 cells,
9 WT mice, p < 0.001). This effect does not seem to result
from deficient CB1 receptor function, as DSI remained un-
affected in RIM1a KO mice (Figure 3B). The differential
sensitivity of I-LTD and DSI to RIM1a deletion parallels
the differential involvement of the cAMP/PKA pathway in
these processes and supports the idea that different
Figure 2. CB1 Receptors Target the Release Machinery via
the cAMP/PKA Pathway
(A) WIN application depressed mIPSC frequency, an effect blocked
by CB1 receptor antagonists (2 mM AM 251, n = 2; 10 mM SR 141716,
n = 3). Sample traces before and during WIN application are shown at
right.
(B) WIN had no effect on mIPSC amplitude.
(C) The WIN-mediated depression of mIPSC frequency is blocked in
the continuous presence of FSK (n = 6) or H89 (n = 5).
Error bars, ± SEM.Neuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc. 803
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and long-term eCB-plasticity.
I-LTD is a heterosynaptic form of plasticity triggered by
both glutamate release from Schaffer collaterals and post-
synaptic activation of group I metabotropic glutamate re-
ceptors (mGluR-I), which stimulates eCB production
(Chevaleyre and Castillo, 2003). Because the probability
of glutamate release in area CA1 of the hippocampus is re-
duced in RIM1a KO mice (Schoch et al., 2002), the loss of
I-LTD could simply be due to a subthreshold activation of
mGluRs. We addressed this possibility in several ways.
First, we found that I-LTD was normal using 10 mM Cd2+,
a nonselective VGCC blocker, which depressed excitatory
transmission in WT mice to a level similar to that of KO
mice (50%, data not shown) (Schoch et al., 2002). Sec-
ond, a 10 min bath application of the mGluR-I agonist
DHPG (50 mM), which bypasses glutamate release and
also triggers I-LTD upon DHPG washout (Chevaleyre and
Castillo, 2003; Edwards et al., 2006), failed to elicit I-LTD in
KO mice (Figure 4A; 4.9% ± 3.3%, n = 5 cells, 4 KO mice,
versus 21.7% ± 1.5%, n = 5 cells, 4 WT mice, p = 0.0002).
Finally, we directly tested the effect of CB1 receptor acti-
Figure 3. Long-Term, but Not Short-Term, eCB-Mediated
Plasticity Requires the Presynaptic Active Zone Protein
RIM1a
(A) TBS delivered in slices from RIM1a KO mice triggered no depres-
sion compared with the I-LTD obtained in WT littermates (18 cells,
10 mice and 14 cells, 9 mice, respectively).
(B) In contrast, DSI was identical in both WT and KO animals. Averaged
sample traces are shown above (A) or on the right (B).
Error bars, ± SEM.804 Neuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc.vation with the CB1 receptor agonist WIN. Because CB1
receptor agonists are lipophilic compounds with slow dif-
fusion kinetics in acute brain slices, for these experiments
we monitored extracellular field IPSPs (fIPSPs) (Arai et al.,
1995; Lambert et al., 1991), which allow for stable long-
term recordings (see Experimental Procedures). In WT
mice, bath application of WIN, subsequently chased
with the CB1 receptor antagonist SR 141716, led to a
lasting depression of fIPSPs (Figure 4B; 23.9% ± 2.8%,
n = 4, 3 mice, p = 0.0006). In RIM1a KO mice, WIN acutely
depressed the fIPSP to the same extent as that observed
in WT mice, but fIPSP amplitude subsequently recovered
Figure 4. Altered Basal Transmission at Excitatory or Inhibi-
tory Synapses Cannot Explain the Lack of I-LTD in RIM1a
KO Mice
(A) Pharmacological induction of I-LTD by DHPG (50 mM, 10 min) was
normal in WT mice (n = 5 cells, 4 mice) but impaired in RIM1a KO mice
(n = 5 cells, 4 mice).
(B) Similarly, application of the CB1 receptor agonist WIN (5 mM,
25 min) subsequently chased with the CB1 receptor antagonist
SR 141716 (5 mM) induced a lasting depression of fIPSPs in WT (four
slices, three animals) but not in RIM1a KO (five slices, three animals)
mice. Sample traces before and after WIN application, as well as in
100 mM picrotoxin, are shown at right.
(C) The average IPSC amplitude (excluding transmission failures), the
failure rate, and the paired-pulse ratio (IPSC2/IPSC1) at CB1R
+ fibers
isolated by focal stimulation were identical in WT (10 cells, 10 mice)
and RIM1a KO mice (13 cells, 11 mice).
Error bars, ± SEM.
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Release at CB1+ Fibers Requires RIM1a
(A) Representative experiments showing the
effect of H89 in WT and RIM1a KO mice using
focal stimulation of CB1R+ fibers. Averaged
sample traces at times indicated by numbers
are shown on the right. Vertical arrows indicate
DSI induction.
(B) Summary graph showing significantly
greater depression of synaptic transmission
(IPSC amplitude, including failures) by H89 in
WT versus RIM1a KO mice (eight cells, eight
mice; nine cells, eight mice, respectively).
Without drug application, no significant
depression was observed over time.
(C) H89 significantly increased failure rate and
paired-pulse ratio (IPSC2/IPSC1) in WT, but
not RIM1a KO, mice (same cells as [B]).
Error bars, ± SEM.to baseline (5.5% ± 1.5%, n = 3, 2 mice, p = 0.0001 com-
pared with WT). The similar transient depression but dif-
ferential long-term effect of WIN at inhibitory synapses
strongly echoes the dissociation of DSI and I-LTD in these
mice. Together, these results show that impaired gluta-
mate release or eCB signaling cannot account for the
lack of I-LTD in RIM1a KO animals.
Perhaps in slices from RIM1a KO mice, CB1 receptor-
expressing fibers (CB1R+) are already depressed, thereby
occluding attempts to induce I-LTD. Because not all inhib-
itory inputs express CB1 receptors, the bulk stimulation
used in previous experiments (see Experimental Proce-
dures), activation of a mixture of CB1R+ and CB1R fibers,
may have led us to underestimate potential changes spe-
cific to CB1R+ fibers. To isolate CB1R+ synaptic inputs,
we lowered the stimulation intensity and selected those in-
puts that exhibited complete block of transmission during
DSI (Chevaleyre and Castillo, 2004) (Figure 4C). We found
that the IPSC amplitude (excluding failures), failure rate,
and paired-pulse ratio of two successive IPSCs were
identical in WT and KO mice (Figure 4D). Taken together,
these results show that the lack of I-LTD in RIM1a KO is
not due to an initial change in release probability at
CB1R+ inhibitory synapses.
Our results so far show that PKA and RIM1a are re-
quired for CB1 receptor-mediated LTD. To confirm that
RIM1a is indeed required for both CB1 receptor and
PKA action on GABA release, we performed two addi-
tional sets of experiments. First, we tested the acute effect
of a PKA blocker on GABA release in both WT and KO
mice. Because PKA may differentially control GABA re-
lease at synapses that do not express the CB1 receptor,
we performed this experiment after isolating CB1R+ fibers
with focal stimulation. As shown in Figure 5, blockade ofPKA by H89 depressed GABAergic synaptic transmission
at CB1R+ inputs, a depression (including failures) that was
significantly attenuated in RIM1a KO mice (Figures 5A and
5B; 35.3% ± 5.8%, n = 8 cells, 8 WT mice versus 15.2% ±
4.8%, n = 9 cells, 8 KO mice, p < 0.01). In the absence of
PKA blocker, transmission remained stable throughout
the experiment (Figure 5B; 95.8% ± 4.7%, n = 7), suggest-
ing that the remaining depression in KO mice probably re-
flects an action of PKA on targets other than RIM1a. A ma-
jor component of the H89-mediated depression of GABA
release is likely RIM1a dependent, as indicated by the in-
crease in failure rate and paired-pulse ratio in WT, but not
in KO, mice (Figures 5C and 5D).
To investigate whether the CB1 receptor-mediated ef-
fect on GABAergic release machinery (Figure 2A) similarly
requires RIM1a, in addition to cAMP/PKA signaling, we
tested the effect of CB1 receptor activation on mIPSC ac-
tivity in WT and KO mice. Again, in order to rule out a con-
tribution of VGCC inhibition to a CB1 receptor-mediated
effect, these experiments were performed in the presence
of 100 mM Cd2+. As shown in Figure 6, WIN-induced de-
pression of mIPSC activity was absent in RIM1a KO
mice (Figure 6). Together, these results indicate that the
PKA/RIM1a pathway is required for CB1 receptor-medi-
ated effects on the release machinery and for long-term,
but not short-term, synaptic plasticity.
Given the widespread prevalence of eCB-dependent
LTD, we tested whether the RIM1a-dependent mecha-
nism of long-term plasticity is conserved in other brain
structures. In the BLA, where eCBs also mediate a form
of I-LTD (Azad et al., 2004; Marsicano et al., 2002), we first
investigated whether CB1 receptors could suppress
GABA release by targeting the release machinery. Indeed,
activation of CB1 receptors by WIN decreased mIPSCNeuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc. 805
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by CB1 receptor antagonists (Figure 7A). WIN induced no
significant effect on mIPSC amplitude (data not shown),
indicating a presynaptic action of CB1 receptors. Impor-
tantly, H89 blocked the WIN-mediated effect on mIPSC
frequency (Figure 7B). These results strongly suggest
that at BLA inhibitory synapses, CB1 receptors target
the release machinery via PKA to depress GABA release.
The coupling of CB1 receptors to GABA release in BLA
parallels our findings in hippocampus and suggests that
CB1 receptor-mediated plasticity in these two structures
may share important features. We first verified that low-
frequency stimulation (LFS, 100 stimuli, 1 Hz) within the
amygdala, close to the external capsule, triggers a CB1
receptor-dependent LTD of IPSCs in the BLA (data not
shown) (Azad et al., 2004; Marsicano et al., 2002). As in
the hippocampus (Figure 3A), BLA I-LTD was abolished
in RIM1a KO mice (Figure 7C;1.7% ± 6.3%, n = 11 cells,
5 KO mice, versus 25.3% ± 2.4%, n = 9 cells, 6 WT mice,
p < 0.0016). In addition, to rule out a potential decrease in
glutamate release during I-LTD induction in KO mice, we
tested whether direct activation of mGluR-I with an ago-
nist could trigger I-LTD in these mice. Similar to the results
observed with LFS, we found that DHPG-evoked LTD was
also abolished in RIM1a KO mice (Figure 7D, 27.6% ±
8.0%, n = 7, 3 WT mice, versus 3.4% ± 4.0%, n = 6, 4
KO mice, p = 0.02). Interestingly, as observed in the hippo-
campus (Figure 4A), the IPSC depression during DHPG
application was identical in both WT and RIM1a KO
mice, indicating that the acute effect of CB1 receptor ac-
tivation on GABA release (Azad et al., 2004) is also inde-
pendent of RIM1a in the amygdala. In conclusion, our re-
Figure 6. RIM1a Mediates CB1 Receptor Action on the Re-
lease Machinery
(A) Sample trace before and after WIN application in WT and RIM1aKO
mice.
(B) Averaged mIPSC frequency plot before and after WIN application in
WT (four cells, three animals) and RIM1a KO (five cells, three animals)
mice.
(C) Bar graph of mIPSC frequency showing the lack of effect of WIN in
RIM1a KO mice.
Error bars, ± SEM.806 Neuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc.sults show that RIM1a is necessary for the long-term
reduction of GABA release induced by CB1 receptors
not only in the hippocampus, but also in the amygdala,
and that in both of these structures, the CB1 receptor-me-
diated effect on release machinery requires PKA.
DISCUSSION
In this study we investigated the mechanism by which ac-
tivation of CB1 receptors triggers a long-lasting reduction
of transmitter release. First, we report in the hippocampus
that eCB-LTD, but not short-term depression, of inhibitory
transmission requires cAMP/PKA signaling. Second, we
identify the active zone protein RIM1a as a critical player
in CB1 receptor-mediated suppression of GABA release.
Finally, we show that RIM1a is necessary for eCB-depen-
dent LTD in both the hippocampus and amygdala. Our
findings support the notion that enduring changes in the
release machinery via cAMP/PKA signaling and RIM1a
represent a general mechanism underlying presynaptic
forms of long-term plasticity.
CB1 Receptors Engage Different Pathways during
Short- and Long-Term eCB-Plasticity
One of the main conclusions of our study is that the signal-
ing pathways downstream of the CB1 receptor that trigger
short- and long-term plasticity differ (Figure 8). The mech-
anism underlying transient suppression of transmitter re-
lease by eCBs, i.e., DSI/DSE, has been extensively stud-
ied in several brain areas (reviewed in Alger, 2002;
Chevaleyre et al., 2006; Diana and Marty, 2004; Freund
et al., 2003; Kreitzer and Regehr, 2002; and Wilson and
Nicoll, 2002). Most experimental evidence indicates that
eCB-mediated short-term plasticity, at least in the hippo-
campus and cerebellum, is mainly due to a CB1 receptor-
mediated reduction of presynaptic Ca2+ influx through
VGCCs. Indeed, at climbing fiber inputs to Purkinje cells,
action potential-induced Ca2+ influx into presynaptic ter-
minals was directly visualized and decreased during
DSE to an extent that fully accounted for the decrease in
EPSC amplitude (Kreitzer and Regehr, 2001). In the hippo-
campus, inhibition of presynaptic N-type VGCCs report-
edly mediates DSI, and this inhibition likely occurs as a re-
sult of the direct action of the Gb/g subunits (Wilson et al.,
2001). In support of this mechanism, early studies in ex-
pression systems showed that Gb/g subunits, but not the
Ga subunit, are responsible for the modulation of N-type
VGCCs (Herlitze et al., 1996; Ikeda, 1996), and that canna-
binoids inhibit N-type VGCC (Mackie and Hille, 1992). In
addition, the fast onset of DSI (1 s) (Heinbockel et al.,
2005; Wilson et al., 2001) is more consistent with a fast,
membrane-delimited pathway of presynaptic inhibition
than a phosphorylation-induced change in channel activ-
ity, which typically requires many seconds and may in-
volve soluble second messengers (Dolphin, 2003; Hesch-
eler and Schultz, 1993; Hille, 1992). Consistent with this
idea, DSI was found to be unaffected by broad spectrum
blockers of protein kinases and phosphatases (Wilson
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Endocannabinoid-Mediated I-LTD Requires PKA/RIM1aFigure 7. RIM1a and PKA Control GABA Release and Inhibitory Synaptic Plasticity in Basolateral Amygdala
(A) WIN depressed mIPSC frequency in BLA (n = 5), an effect blocked by CB1 receptor antagonists (5 mM AM 251, n = 2; 5 mM SR131716, n = 2).
Sample traces are shown on the right.
(B) WIN-mediated depression was blocked by H89 (n = 5).
(C) LTD induction was blocked in RIM1a KO mice (11 cells, five mice) compared with their WT littermates (9 cells, six mice).
(D) LTD induced pharmacologically by DHPG (50 mM, 15 min) was also abolished in RIM1a KO mice compared with WT mice (seven cells, three WT
mice and six cells, four KO mice).
Error bars, ± SEM.et al., 2001) and by manipulation of the cAMP pathway
(Morishita et al., 1998; Wilson et al., 2001). Our study con-
firms these observations, thereby supporting the notion
that DSI is unlikely to be mediated by adenylyl cyclase in-
hibition. Furthermore, we demonstrate that both cAMP/
PKA signaling and RIM1a are necessary for I-LTD, but
not DSI.
Previous studies at both inhibitory (Chevaleyre and Cas-
tillo, 2003) and excitatory (Ronesi et al., 2004) synapses
have shown that the induction of eCB-mediated LTD re-
quires CB1 receptor activation for several minutes, and
that once this form of plasticity is induced, it becomes in-
dependent of CB1 receptor activation. The relatively long
induction period suggests that CB1 receptors may en-
gage a different signaling process than the one mediating
transient suppression of transmitter release. Indeed, the
fast time course of DSI (<1 min) likely reflects the transient
profile of eCB production and CB1 receptor engagement
since CB1 receptor desensitization does not occur within
this time window. Therefore, it is tempting to speculate
that DSI requires neither cAMP/PKA signaling nor RIM1a
because CB1 receptor activation is too brief to signifi-
cantly engage the ai/o effector limb of the G protein
signaling cascade. Our findings are consistent with a
model (Figure 8) whereby brief activation of CB1
receptors, presumably by blocking presynaptic VGCCs
via Gb/g subunits (Wilson et al., 2001), leads to short-term depression of transmitter release. In contrast,
a more sustained, but still transient activation of CB1 re-
ceptors (Chevaleyre and Castillo, 2003; Ronesi et al.,
2004) downregulates the cAMP/PKA signaling pathway
(Childers and Deadwyler, 1996; Howlett et al., 1986), per-
haps via the Ga subunit, thereby triggering a RIM1a-
dependent modification in the release machinery to
suppress transmitter release in a long-lasting manner.
CB1 Receptors Can Control Synaptic Transmission
by Targeting the Release Machinery in a PKA-
and RIM1a-Dependent Manner
Most studies have shown that CB1 receptor-mediated
suppression of GABA release mainly occurs as a result
of presynaptic VGCC modulation (Diana and Marty,
2003; Hajos et al., 2000; Hoffman and Lupica, 2000;
Varma et al., 2002; Wilson et al., 2001). Consistent with
this mechanism, activation of CB1 receptors depressed
the frequency of spontaneous IPSCs (action potential-
driven events), but not mIPSC frequency, monitored under
normal extracellular Ca2+ concentration in the hippocam-
pus (Alger et al., 1996; Hajos et al., 2000; Hoffman and
Lupica, 2000; Pitler and Alger, 1994; Varma et al., 2002;
Wilson et al., 2001) and the amygdala (Azad et al., 2003;
Katona et al., 2001). Taken together, these observations
could be interpreted to mean that CB1 receptors do not
target the release machinery. In the cerebellum, however,Neuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc. 807
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stream of Ca2+ influx (Diana and Marty, 2003; Takahashi
and Linden, 2000). A recent report demonstrated that
the CB1 receptor-mediated effect on miniature synaptic
events depends on basal Ca2+ in the presynaptic terminal
(Yamasaki et al., 2006). A similar observation was also
reported in the amygdala (Azad et al., 2003). Thus, in the
absence of action potentials—i.e., in the presence of
TTX—and in blockers of presynaptic Ca2+ influx, quantal
release may still depend on basal Ca2+ in the terminal (Ya-
masaki et al., 2006), and it is likely that Ca2+ released from
intracellular stores plays an important role in this process
(Collin et al., 2005). It is therefore conceivable that de-
creasing presynaptic Ca2+, a likely consequence of con-
tinuous action potential blockade with TTX, may mask
any CB1 receptor-mediated (Ca2+-dependent) effect on
the release machinery in normal extracellular Ca2+.
We now show in the CA1 area of the hippocampus that
after blocking action potentials and Ca2+ influx through
VGCCs, CB1 receptors suppress mIPSC frequency (al-
though in 5 mM extracellular Ca2+). Early studies have
demonstrated that presynaptic Gi/o protein-coupled re-
ceptors can suppress transmitter release downstream of
Ca2+ influx, presumably by targeting the release machin-
ery (Cohen et al., 1992; Dittman and Regehr, 1996; Gereau
and Conn, 1995; Jarolimek and Misgeld, 1997; Poncer
et al., 1995; Scanziani et al., 1992, 1995; Scholz and Miller,
1992; Umemiya and Berger, 1995). While a similar mech-
anism may contribute to the CB1 receptor-mediated sup-
pression of transmitter release at some synapses (Szabo
and Schlicker, 2005), the precise signaling pathway and
Figure 8. Model of the Divergent Signaling Pathways Down-
stream of the CB1 Receptor that Trigger eCB-Mediated
Short- or Long-Term Depression
During eCB-mediated short-term depression, brief activation of CB1
receptors reversibly depresses neurotransmitter release, mainly by
blocking presynaptic VGCC, presumably via Gb/g subunits. In contrast,
during the induction of eCB-mediated LTD, a longer-lasting (i.e., few
minutes) (Chevaleyre and Castillo, 2003; Ronesi et al., 2004) activation
of CB1 receptors inhibits adenylyl cyclase (AC) activity via Ga subunits,
thereby reducing presynaptic cAMP levels and PKA activity. This mod-
ification ‘‘gates’’ an enduring change of the release machinery that re-
quires the active zone protein RIM1a. PKA may directly phosphorylate
RIM1a, other associated proteins, or a combination thereof.808 Neuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc.identity of CB1 receptor targets have been largely unex-
plored. Our results demonstrate that CB1 receptors can
target the release machinery via the cAMP/PKA pathway.
Moreover, we provide evidence that both PKA and CB1
receptor action on GABA release depends on the pres-
ence of the active zone protein RIM1a.
Previous studies have suggested that CB1 receptor ag-
onists suppress action potential-driven synaptic re-
sponses independently of PKA (Azad et al., 2003; Daniel
et al., 2004; Huang et al., 2002; Robbe et al., 2001). While
these data seem to conflict with our model (Figure 8), ag-
onist application likely engages multiple pathways down-
stream of CB1 receptors. Any one of these mechanisms
could suppress transmitter release to such an extent
that a concurrent PKA-dependent change at the level of
the release machinery could go undetected. Finally, our
findings are consistent with previous reports showing
that cAMP/PKA signaling enhances inhibitory synaptic
transmission by increasing release probability indepen-
dently of presynaptic Ca2+ influx, not only in the hippo-
campus (Capogna et al., 1995; Sciancalepore and Cheru-
bini, 1995; Trudeau et al., 1996) but also in the cerebellum
(Kondo and Marty, 1997; Llano and Gerschenfeld, 1993;
Saitow et al., 2005).
It is likely that PKA-dependent modulation of transmitter
release occurs as a result of the phosphorylation of pre-
synaptic proteins involved in exocytosis (for a recent re-
view see Seino and Shibasaki, 2005). RIM1a emerges as
a unique candidate, as this presynaptic protein is phos-
phorylated by PKA and its phosphorylation reportedly en-
hances glutamate release in cerebellum (Lonart et al.,
2003). RIM1a has been exclusively localized to presynap-
tic nerve terminals in rodents (Wang et al., 1997) and in
C. elegans (Koushika et al., 2001; Weimer et al., 2006).
In situ hybridization studies suggest that RIM1a is ex-
pressed in all neurons (Schoch et al., 2006). Furthermore,
immunohistochemistry evidence in the hippocampus
shows that RIM1a is coexpressed with GAD67 (S. Schoch,
personal communication), indicating that RIM1a is pres-
ent in GABAergic interneurons. In this context, it is tempt-
ing to speculate that activation of CB1 receptors, presum-
ably by a reduction of PKA activity, may lead to a decrease
in RIM1a phosphorylation. However, it is formally possible
that some other RIM1a partner, also phosphorylated by
PKA, may mediate the CB1 receptor-induced effects on
the release machinery.
PKA/RIM1a as a General Mechanism
for Presynaptic Plasticity
RIM1a is a key protein in the active zone (Wang et al.,
1997) that regulates neurotransmitter release (Calakos
et al., 2004; Koushika et al., 2001; Schoch et al., 2002),
and it is thought to scaffold and organize the synaptic re-
lease machinery (Sudhof, 2004). Its selective localization
to active zones and its interactions with multiple presyn-
aptic molecules places RIM1a in a strategic position to
modulate presynaptic release and plasticity (Kaeser and
Sudhof, 2005). In addition, RIM1a KO mice show
Neuron
Endocannabinoid-Mediated I-LTD Requires PKA/RIM1asignificant cognitive deficits (Powell et al., 2004). Previous
studies reported that RIM1a is critical for the long-term en-
hancement of glutamate release associated with PKA-
dependent, NMDA receptor-independent presynaptic forms
of LTP at excitatory synapses in both the hippocampus
(Castillo et al., 2002) and the cerebellum (Castillo et al.,
2002; Lonart et al., 2003). More recently, Huang et al.
(2005) have described a role for RIM1a in the PKA-depen-
dent late phase of LTP at Schaffer collateral to CA1 pyra-
midal cell synapses. It is worth noting that all these studies
identified a role for RIM1a exclusively in excitatory LTP.
We now demonstrate that CB1 receptor-dependent LTD
at inhibitory synapses requires RIM1a. In addition, we
show that cAMP/PKA signaling is necessary for hippo-
campal I-LTD. Enduring changes in the release machinery
mediated by PKA signaling and RIM1a represent a wide-
spread mechanism underlying presynaptic regulation of
long-term plasticity (LTP and LTD) at both excitatory and
inhibitory synapses.
I-LTD as a Substrate for Learning and Memory
Disrupting eCB-CB1 receptor signaling has a variety of ef-
fects on both hippocampus- and amygdala-dependent
memory tasks (Chhatwal et al., 2005; Kamprath et al.,
2006; Marsicano et al., 2002; Mikics et al., 2006; Suzuki
et al., 2004; Varvel et al., 2005, 2006; Varvel and Lichtman,
2002). However, the precise role of this pathway, let alone
I-LTD, in learning and memory still remains to be fully un-
derstood. Unlike manipulations involving the CB1 recep-
tor, RIM1a KO maintain short-term eCB-mediated plastic-
ity (DSI) without the long-term form (I-LTD). These mice
have striking deficits in acquiring both hippocampus-
and amygdala-dependent memories (Powell et al.,
2004). I-LTD strongly modulates excitability and induction
of LTP in both brain areas (Azad et al., 2004; Chevaleyre
and Castillo, 2004), so it is possible that this process, to-
gether with other deficits in synaptic function (Huang
et al., 2005; Kaeser and Sudhof, 2005), could contribute
to the RIM1a KO phenotype. Selective disruption of the
RIM1a pathway in a subset of synaptic inputs (e.g., those
expressing CB1 receptors) may help to establish the con-
tribution of eCB-mediated long-term plasticity to learning
and memory.
EXPERIMENTAL PROCEDURES
Experiments were performed in C57Bl/6 mice (3–6 weeks; Charles
River), paired RIM1a KO and WT mouse littermates (3–6 weeks), or
Wistar rats (3–5 weeks; Charles River). RIM1aKO mice were generated
as described previously (Schoch et al., 2002). Transverse hippocampal
slices were prepared as described elsewhere (Chevaleyre and Castillo,
2003). Animals were killed by decapitation in accordance with institu-
tional regulations. Slices (400 mm thickness) were cut on a vibrating
slicer (Dosaka, Kyoto, Japan) in ice-cold extracellular solution contain-
ing 215 mM sucrose, 2.5 mM KCl, 20 mM glucose, 26 mM NaHCO3,
1.6 mM NaH2PO4, 1 mM CaCl2, 4 mM MgSO4, and 4 mM MgCl2.
The cutting medium was gradually switched to the recording solution
(ACSF) that contained 124 mM NaCl, 2.5 mM KCl, 10 mM glucose,
26 mM NaHCO3, 1 mM NaH2PO4, 2.5 mM CaCl2, and 1.3 mM
MgSO4. Slices were kept at room temperature for at least 1.5 hr beforerecording. Cutting and recording solutions were saturated with 95%
O2 and 5% CO2 (pH 7.4). Experiments were performed at 25.0
C ±
0.1C except for mIPSC recordings (28.0C).
CA1 pyramidal cells were blind-patched and recorded in whole-cell
voltage-clamp mode. For recording IPSCs, hippocampal slices were
completely submerged and continuously superfused at a flow rate of
2 ml/min with ACSF containing NMDA and AMPA/Kainate receptor an-
tagonists (25 mM d-APV and 10 mM NBQX). Constant-voltage synaptic
stimulation (200 ms pulse width) was delivered in pairs (100 ms inter-
stimulus interval) via a patch-type pipette filled with ACSF and placed
in the middle third of S. radiatum. For experiments with bulk stimula-
tion, stimulation pipette tips were broken to 20 mm and IPSCs were
recorded at 60 mV for DSI or +10 mV for I-LTD with an internal solu-
tion containing 123 mM cesium gluconate, 1 mM CaCl2, 10 mM EGTA,
10 mM HEPES, 10 mM glucose, 5 mM ATP, and 0.4 mM GTP (pH 7.2;
280–290 mOsm). We adjusted stimulus intensity to evoke IPSCs of
comparable amplitudes across experiments (0.5–1.4 nA). All mIPSCs
were recorded with the same internal solution at +20 mV and ACSF
containing 500 nM TTX, 100 mM CdCl2, 5 mM CaCl2, 25 mM d-APV,
and 10 mM NBQX. For focal stimulation experiments, IPSCs were
recorded at 60 mV with an internal solution containing CsCl instead
of cesium gluconate. The stimulus strength for these experiments
was reduced to elicit small-amplitude IPSCs (30 pA) and a 10%
failure rate over >10 min baseline. Series resistance (Rs, typically
8–15 MU) was continuously monitored throughout each experiment
with a 5 mV, 80 ms command pulse delivered prior to each stimulus
pair; cells with more than 10% change in Rs were excluded from anal-
ysis. I-LTD was induced after a stable baseline by TBS consisting of a
series of ten bursts of five stimuli (100 Hz within each burst, 200 ms
interburst interval, repeated four times, 5 s apart). I-LTD magnitude
was quantified by averaging IPSC amplitudes for 10 min periods right
before and 20 min after TBS. DSI was evoked by a 5 s voltage step
from 60 mV to 0 mV. Typically 2–3 DSIs per cell were averaged prior
to group statistical analysis. The peak inhibition during DSI was quan-
tified by averaging IPSC amplitudes 6 and 12 s after depolarization.
IPSCs were monitored every 6 s for DSI and every 20 s for I-LTD.
Five- to ten-second epochs were obtained every fifteen seconds for
mIPSC analysis. Extracellular field recordings were performed using
recording pipettes filled with 1M NaCl. For fEPSPs stimulating and re-
cording pipettes were placed in the middle third of CA1 S. radiatum.
fIPSP experiments in CA1 were performed under the same recording
conditions as whole-cell IPSC experiments, except that stimulation and
recording pipette tips were both placed in S. pyramidale 150 mm
apart. Stimulating and recording pipettes were placed at a similar depth
within the tissue for each experiment (80–100 mm). Stimulation intensity
was adjusted to produce 0.2–0.4 mV fIPSP. In each experiment, we
confirmed that these potentials were completely blocked by the
GABA-A receptor antagonist picrotoxin (100 mM), in accordance with
previously published reports (Lambert et al., 1991; Arai et al., 1995).
For experiments performed in BLA, coronal slices were prepared
from 4–8 week old male C57Bl/6 mice using similar methods as de-
scribed above. Principal cells in the BLA were identified by their mor-
phological and electrophysiological characteristics (Washburn and
Moises, 1992). IPSCs were recorded from principal cells in the basal
nucleus using the same internal solution as for focal stimulation in hip-
pocampus, voltage clamped between 60 mV and 70 mV. Synaptic
responses were evoked as paired-pulse stimuli (200 ms pulse width,
50 ms apart) via monopolar ACSF-filled patch-type pipettes with bro-
ken tips (20 mm) placed just medial to the external capsule. I-LTD was
triggered with LFS (100 stimuli at 1 Hz, intensity twice that of test
pulses). Recording conditions for mIPSCs were identical to those for
hippocampus.
Whole-cell and extracellular recordings were performed with a Multi-
Clamp 700A amplifier (Axon Instruments Inc., Union City, CA) whose
output signals were filtered at 3 kHz, acquired at 5 kHz, and analyzed
on-line using customized software for IgorPro (Wavemetrics Inc.,
Lake Oswego, OR). Results are reported as mean ± SEM. Error barsNeuron 54, 801–812, June 7, 2007 ª2007 Elsevier Inc. 809
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Student’s t test. Unless otherwise stated, drugs were bath applied
following dilution into the ACSF from concentrated stock solutions.
SR 141716 (NIMH), H89 (Sigma-Aldrich), FSK (Calbiochem), NBQX,
AM 251, WIN, and CP 55,940 (Tocris) were dissolved in DMSO. d-APV,
DHPG (Tocris), PKI 14-22 amide (cell permeable, myristoylated) and
PKA inhibitor 6-22 amide (Calbiochem) were dissolved in water. For
experiments involving drug treatment of slices, interleaved controls
were performed in the same concentration of the respective solvent.
Stock solutions of drugs were stored at 20C prior to use. RIM1a
KO and WT littermates were shipped to Albert Einstein College of Med-
icine (Bronx, NY) unidentified, and data were acquired and analyzed
in a blind fashion; the KO mice exhibit no obvious phenotype (Schoch
et al., 2002). Genotype was confirmed afterward by PCR using tail
DNA.
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